莱茵生物: 第七届监事会第五次会议决议公告

Group 1 - The company held its seventh supervisory board's fifth meeting on August 20, 2025, which was conducted via telecommunication and was attended by all supervisory members and executives [2][4]. - The supervisory board unanimously agreed to reduce the investment scale of certain fundraising projects, conclude some fundraising projects, and permanently supplement the remaining raised funds into working capital [3][4]. - The decision to reduce the investment scale and conclude projects is based on the company's current situation and aims to improve the efficiency of fund usage and lower financial costs, benefiting the company and all shareholders, particularly minority shareholders [2][3]. Group 2 - The meeting was legally valid and complied with the Company Law of the People's Republic of China and the company's articles of association [2]. - The company will publish detailed information regarding the reduction of fundraising investment scale and the conclusion of projects in major financial newspapers and platforms [3][4].